As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic ... Those with end-stage kidney disease ...

Ozempic, Wegovy and Mounjaro are often the most popular weight loss drugs. While these medications help people lose weight, ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...